Clinically Proven Safety with an Impeccable Track Record
Minitouch has been rigorously tested in FDA clinical trials in the U.S. and over a decade of real-world use in the U.K., confirming its exceptional safety profile, minimal complications, and high patient satisfaction. Unlike older endometrial ablation devices that rely on high-temperature energy, uterine distension, or mechanical pressure, Minitouch uses a gentle, low-temperature electromagnetic field to minimize risks while ensuring consistent, long-term results.
FDA Trial: Proven Safety in a Rigorous U.S. Clinical Study
Before receiving FDA approval, Minitouch underwent a controlled, multicenter clinical trial to evaluate its safety and effectiveness. The results demonstrated:
These results confirm that Minitouch provides a safer alternative to hysterectomy and second-generation ablation devices while maintaining high patient satisfaction and long-term success.
95% of patients reported reduced period pain, with 71% experiencing no pain at all
UK Experience: 10+ Years of Real-World Success
Minitouch has been used in the United Kingdom for over a decade, with thousands of successful procedures performed in real-world clinical settings.
Key findings from the U.K. experience include:
This extensive real-world experience reinforces Minitouch’s proven track record of safety and reliability.
01
High patient satisfaction with minimal side effects
02
No reported cases of uterine perforation or long-term complications
03
Comparable or better outcomes than traditional ablation methods
With FDA approval, 10+ years of clinical success in the U.K.
and an impeccable safety record, Minitouch sets a new standard for safe, effective, and patient-friendly endometrial ablation.